CLPT
Clearpoint Neuro Inc
NASDAQ: CLPT · HEALTHCARE · MEDICAL DEVICES
$11.18
+8.12% today
Updated 2026-04-30
Market cap
$353.24M
P/E ratio
—
P/S ratio
9.55x
EPS (TTM)
$-0.90
Dividend yield
—
52W range
$8 – $30
Volume
0.8M
WallStSmart proprietary scores
37
out of 100
Grade: D
Sell
Investment rating
8.0
Growth
A4.5
Quality
C2.0
Profitability
F6.3
Valuation
B3/9
Piotroski F-Score
Weak
-6.1
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$25.00
+123.61%
12-Month target
—
—
Intrinsic (DCF)
$15.39
Margin of safety
+13.13%
0 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Revenue growth 34.00% QoQ
+ 13.13% below intrinsic value
Risks
- Piotroski 3/9 — weak financial health
- Altman Z -6.12 — distress zone
- Thin margins at -69.10%
- Negative free cash flow $-12.13M
- Debt/equity 2.25x — high leverage
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $20.55M | $23.95M | $31.39M | $36.97M | $36.97M |
| Net income | $-16.43M | $-22.09M | $-18.91M | $-25.54M | $-7.79M |
| EPS | — | — | — | — | $-0.90 |
| Free cash flow | $-16.42M | $-14.44M | $-9.22M | $-24.45M | $-12.13M |
| Profit margin | -79.97% | -92.21% | -60.25% | -69.08% | -69.10% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-04-01 | RICHARDS, TIMOTHY T. | Buy | 442 | $9.10 |
| 2026-04-01 | GIRIN, PASCAL E R | Buy | 755 | $9.10 |
| 2026-04-01 | FLETCHER, R JOHN | Buy | 1,270 | $9.10 |
Peer comparison
Smart narrative
Clearpoint Neuro Inc trades at $11.18. Our Smart Value Score of 37/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -6.12, it sits in the distress. TTM revenue stands at $36.97M. with profit margins at -69.10%. Our DCF model estimates intrinsic value at $15.39.
Frequently asked questions
What is Clearpoint Neuro Inc's stock price?
Clearpoint Neuro Inc (CLPT) trades at $11.18.
Is Clearpoint Neuro Inc overvalued?
Smart Value Score 37/100 (Grade D, Sell). DCF value $15.39.
What is the price target of Clearpoint Neuro Inc (CLPT)?
The analyst target price is $25.00, representing +123.6% upside from the current price of $11.18.
What is the intrinsic value of Clearpoint Neuro Inc (CLPT)?
Based on our DCF model, intrinsic value is $15.39, a +13.1% margin of safety versus $11.18.
What is Clearpoint Neuro Inc's revenue?
TTM revenue is $36.97M.
Piotroski F-Score?
3/9 — weak financial health.
Altman Z-Score?
-6.12 — distress.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio9.55x
ROE-95.60%
Beta1.18
50D MA$10.90
200D MA$14.06
Shares out0.03B
Float0.03B
Short ratio—
Avg volume0.8M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—